Archive
Back to homepage
Yuyu Pharma appoints Robert Wonsang Yu as incoming President and CEO
SEOUL, South Korea, April 6, 2020 /PRNewswire/ — Yuyu Pharma (KRX: 000220), a global pharmaceutical company based in Korea, is pleased to announce the appointment of Mr. Robert Wonsang Yu as President and Chief Executive Officer effective April 6, 2020.
Read More
Samsung Biologics enters into a development and manufacturing partnership with PharmAbcine for oncology and neovascular treatment
SONGDO, South Korea, April 6, 2020 /PRNewswire/ — Samsung Biologics (207940.KS) entered into a strategic partnership with PharmAbcine for the development and manufacturing of PMC-402 pipeline, a next generation therapeutic antibody candidate to treat oncology and neovascular disorders. Under this agreement,
Read More